Testosterone deficiency: a common, unrecognized syndrome (Q37208303)

18 August 2017

1 reference

title

Testosterone deficiency: a common, unrecognized syndrome (English)

1 reference

18 August 2017

1 reference

1 reference

Jacques L Tostain

1

1 reference

PubMed ID

18604225

18 August 2017

François Blanc

series ordinal

2

1 reference

PubMed ID

18604225

18 August 2017

language of work or name

English

0 references

publication date

1 July 2008

1 reference

18 August 2017

Nature Reviews Urology

1 reference

18 August 2017

5

1 reference

18 August 2017

7

1 reference

18 August 2017

388-396

1 reference

https://scigraph.springernature.com/pub.10.1038/ncpuro1167

18 August 2017

0 references

cites work

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Blood testosterone threshold for androgen deficiency symptoms

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

The burden of testosterone deficiency syndrome in adult men: economic and quality-of-life impact

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Testosterone Deficiency Syndrome (TDS) needs to be named appropriately--the importance of accurate terminology

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

The decline of androgen levels in elderly men and its clinical and therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Frailty and the aging male.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Is there a clinical relevance of partial androgen deficiency of the aging male?

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Comparison of screening questionnaires for the diagnosis of hypogonadism

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Perception of males' aging symptoms, health and well-being in elderly community-dwelling men is not related to circulating androgen levels

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

ANDROTEST: a structured interview for the screening of hypogonadism in patients with sexual dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Andropause and psychopathology: minor symptoms rather than pathological ones

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Gonadal dysfunction in systemic disorders

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Role of endocytosis in cellular uptake of sex steroids.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Defining the prevalence and incidence of androgen deficiency in aging men: where are the goal posts?

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Diurnal testosterone levels in peripheral plasma of human male subjects

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Loss of circadian rhythmicity in blood testosterone levels with aging in normal men

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Diurnal rhythms of serum total, free and bioavailable testosterone and of SHBG in middle-aged men compared with those in young men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Prevalence of hypogonadism in males aged at least 45 years: the HIM study

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Functional testosterone: biochemical assessment of hypogonadism in men--report from a multidisciplinary workshop hosted by the Ontario Society of Clinical Chemists

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Association of specific symptoms and metabolic risks with serum testosterone in older men

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Androgen receptor gene CAG repeat length and body mass index modulate the safety of long-term intramuscular testosterone undecanoate therapy in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Hypogonadism and androgen deficiency symptoms in testicular cancer survivors

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Risk factors in predicting a poor response to sildenafil citrate in elderly men with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Low serum testosterone and mortality in older men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

When is bioavailable testosterone a redundant test in the diagnosis of hypogonadism in men?

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Andropause: introducing the concept of 'relative hypogonadism' in aging males

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Prevalence of symptomatic androgen deficiency in men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Serum androgen levels in black, Hispanic, and white men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Andropause: an old concept in new clothing

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Andropause: is androgen replacement therapy indicated for the aging male?

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

47,XXY (Klinefelter syndrome) and 47,XYY: estimated rates of and indication for postnatal diagnosis with implications for prenatal counselling

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Hypogonadism following prostate-bed radiation therapy for prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Prevalence of and risk factors for androgen deficiency in middle-aged men in Hong Kong

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

The association between obesity and the diagnosis of androgen deficiency in symptomatic ageing men

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

The metabolic syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Endogenous sex hormones and metabolic syndrome in aging men.

1 reference

https://api.crossref.org/works/10.1038%2FNCPURO1167

7 January 2021

Identifiers

DOI

10.1038/NCPURO1167

1 reference

18 August 2017

1 reference

PubMed ID

18604225